LT3978B - New pharmaceutical formulations - Google Patents
New pharmaceutical formulations Download PDFInfo
- Publication number
- LT3978B LT3978B LTIP1714A LTIP1714A LT3978B LT 3978 B LT3978 B LT 3978B LT IP1714 A LTIP1714 A LT IP1714A LT IP1714 A LTIP1714 A LT IP1714A LT 3978 B LT3978 B LT 3978B
- Authority
- LT
- Lithuania
- Prior art keywords
- methylthiazole
- hydroxyethyl
- chloro
- treatment
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP1714A LTIP1714A (en) | 1995-09-25 |
LT3978B true LT3978B (en) | 1996-06-25 |
Family
ID=20380161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP1714A LT3978B (en) | 1990-08-15 | 1993-12-30 | New pharmaceutical formulations |
Country Status (26)
Country | Link |
---|---|
US (1) | US5385921A (pt) |
EP (1) | EP0619734B1 (pt) |
JP (1) | JP3094077B2 (pt) |
AT (1) | ATE164066T1 (pt) |
AU (1) | AU657490B2 (pt) |
BG (1) | BG97446A (pt) |
CA (1) | CA2088775A1 (pt) |
CZ (1) | CZ279586B6 (pt) |
DE (1) | DE69129126T2 (pt) |
DK (1) | DK0619734T3 (pt) |
ES (1) | ES2114891T3 (pt) |
FI (1) | FI930608A0 (pt) |
HU (1) | HUT65821A (pt) |
IE (1) | IE912818A1 (pt) |
IL (1) | IL99169A (pt) |
IS (1) | IS3743A7 (pt) |
LT (1) | LT3978B (pt) |
LV (1) | LV10921B (pt) |
NO (1) | NO303447B1 (pt) |
NZ (1) | NZ239329A (pt) |
PT (1) | PT98688B (pt) |
RO (1) | RO112994B1 (pt) |
RU (1) | RU2093155C1 (pt) |
SE (1) | SE9002659D0 (pt) |
SK (1) | SK8793A3 (pt) |
WO (1) | WO1992003134A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
US6699866B2 (en) | 2001-04-17 | 2004-03-02 | Sepracor Inc. | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
CN103772313B (zh) * | 2014-01-02 | 2015-10-14 | 郑桂富 | 一种4-甲基-5-(2-羟乙基)噻唑的合成方法 |
CN112262814A (zh) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | 油樟叶渣发酵床养鸡方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0230370A2 (en) | 1986-01-14 | 1987-07-29 | MERCK SHARP & DOHME LTD. | Use of specific N-methyl-D-aspartate receptor antagonists in the prevention and treatment of neurodegeneration |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2825966A1 (de) * | 1978-06-14 | 1980-01-03 | Basf Ag | Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
-
1991
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-11 FI FI930608A patent/FI930608A0/fi unknown
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0230370A2 (en) | 1986-01-14 | 1987-07-29 | MERCK SHARP & DOHME LTD. | Use of specific N-methyl-D-aspartate receptor antagonists in the prevention and treatment of neurodegeneration |
Non-Patent Citations (5)
Title |
---|
B. J. ALPS: "Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil", BR J PHARMACOL., 1988, pages 877 - 883 |
ENDE E. ET AL.: "Urinary metabolites of chlormethiazole", ARZNEIMITTEL FORSCH, 1979, pages 1655 - 1658 |
GILL R, FOSTER AC, WOODRUFF GN.: "Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil", J NEUROSCI., 1987, pages 3343 - 3349 |
OFFEN CP, FREARSON MJ, WILSON K, BURNETT D.: "4,5-Dimethylthiazole-N-oxide-S-oxide: a metabolite of chlormethiazole in man", XENOBIOTICA, 1985, pages 503 - 511 |
PAL R, SPITELLER G.: "Thiomethylation and thiohydroxylation--a new pathway of metabolism of heterocyclic compounds", XENOBIOTICA, 1982, pages 813 - 820 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2379300C2 (ru) | Ингибиторы gsk-3 | |
EP0811623A1 (de) | Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten | |
US4304782A (en) | Psychotropic deuterated derivatives of phenylhydantoin and pharmaceutical compositions comprising such derivatives | |
HU188058B (en) | Process for preparing chyralic benzyl-mercapto-propionil-amino derivatives | |
KR930001835B1 (ko) | 신규 히단토인(Hydantoin) 유도체의 제조방법 | |
DE3876402T2 (de) | N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid-derivate und deren verwendung als kollagenase-inhibitoren. | |
LT3978B (en) | New pharmaceutical formulations | |
WO2007045761A1 (fr) | Derives d'amidine et leurs applications a titre de medicament | |
EP0475214B1 (en) | Caffeic acid derivatives and pharmaceutical compositions containing the same | |
PL179021B1 (pl) | Nowa pochodna (1-fenylo-1-heterocyklo)alkanu,sposób wytwarzania nowej pochodnej (1-fenylo-1-heterocyklo)alkanui kompozycja farmaceutyczna PL PL PL PL PL | |
SK160095A3 (en) | Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives | |
JP2011500641A (ja) | 医薬用途の新規なスルファメート化合物 | |
LU86405A1 (fr) | Derive antipsychotique du benzisothiazole s-oxyde | |
JP2009520813A (ja) | カルバメート系抗生物質 | |
WO2017202266A1 (zh) | 一种2-氨基-3-取代巯基丙酸酯衍生物,制备方法及其应用 | |
EP0337350B1 (en) | Use of dimethylheptylphenyl butanoyl ethanolamine in treatment of hyperuricemia | |
JPH0138089B2 (pt) | ||
DE68907893T2 (de) | Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten. | |
KR20010041661A (ko) | 세포분열 억제제 | |
JPS58208256A (ja) | α−メチル−3,4−ジヒドロキシフエニルアラニン誘導体の製法 | |
US20100305157A1 (en) | derivatives of dicarboxylic amino acids and their application in the treatment of neurodegenerative diseases | |
Attia et al. | Research Article Anticonvulsant Potential of Certain New (2E)-2-[1-Aryl-3-(1H-imidazol-1-yl) propylidene]-N-(aryl/H) hydrazinecarboxamides | |
WO2000014073A1 (fr) | Derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions | |
JPH07309757A (ja) | βアミロイド蛋白神経細胞毒性低減剤 | |
FR2892415A1 (fr) | Derives d'amidine et leurs applications a titre de medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 19971230 |